Detalhe da pesquisa
1.
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
Oncologist
; 25(12): e2013-e2016, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918789
2.
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
Support Care Cancer
; 28(2): 561-570, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089820
3.
Increased incidence of co-trimoxazole induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
Br J Dermatol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753744
4.
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233964
5.
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma.
ESMO Open
; 5(4)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641348
6.
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre.
Clin Sarcoma Res
; 10: 1, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911828
7.
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.
Med Oncol
; 35(10): 131, 2018 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128716
8.
Prognostic score for patients with advanced melanoma treated with ipilimumab.
Eur J Cancer
; 51(18): 2785-91, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26597444